Ovarian Cancer Screening Prevention


For years Ovarian Cancer has been appropriately referred to as the ‘silent killer’. This is because the disease is common (1 in 55 women), serious and silent in the early stages. In the United  States alone we see 21,300 new cases and 14,200 deaths annually.  Despite major  surgery, major  chemotherapy and occasional radiation resulting in high morbidity, note the high overall death to incidence  rate. Less that

15% are found  early (Stage I and early Stage II) with routine annual exams or by waiting for symptoms to occur. The GOOD NEWS is that early stage ovarian cancer has a 92+% 5-year survival rate when found  localized in the early stages and treated with simple surgery alone (no chemotherapy or radiation required).

So how do we find Ovarian  Cancer early?

By screening with trans-vaginal ultrasound (sonogram)  or TVS. This is a simple, safe, non-invasive,  effective, painless and very practical  way to detect ovarian  cancer and other  forms  of pelvic cancer including occult endo-cervical,  endometrial, fallopian tube, ovarian and peritoneal. Ca-125 and/or other  blood  testing biomarkers are not effective nor recommended for first line screening.

Those tests may be useful to better characterize the potential for malignancy in the presence of an ovarian or fallopian tube abnormality. We offer  evidence-based, state-of-the-art, high-definition TVS screening for women’s pelvic cancers utilizing  the Yale University,  University of Kentucky and England (United Kingdom)

protocols. This technique is very effective, comfortable and does NOT require a full bladder. With over 34 years of experience in interpretation and clinical correlation, false positive  results and the potential for unnecessary  surgery for benign conditions are not a problem in our practice.

Our Mission

To reduce the mortality and morbidity of women’s cancers through education, prevention, and early detection.

Candidates for Evaluation

Any woman  25 to 90 years of age with a life expectancy of 5 or more years with the presence of one or both ovaries.